Skip to main content
Investor Relations Contact Us Careers
Nasdaq: FEMY
Fertility Portfolio

Women deserve more options than IVF or outdated IUI.

As birth rates reach record lows and access to fertility specialists remains limited, OB/GYNs can play a greater role in earlier diagnosis and treatment, either directly in their practices or in partnership with fertility specialists.

Explore our products Fertility FastTrack™ →
OB/GYN consulting with a patient
The Challenge

Fertility care is too often
delayed, fragmented, and costly.

Millions of women face significant barriers to accessing the fertility care they need. The current pathway causes many to delay treatment or choose not to pursue care.

~10M
women in the U.S. with infertility¹
~50%
of infertile women never take action²
~1%
of infertile women undergo IVF each year³
  1. 1. https://www.cdc.gov/nchs/nsfg/key_statistics/i-keystat.htm
  2. 2. Nugent CN, Chandra A. Use of fertility services in women ages 20–49 in the United States: 2022–2023. NCHS Data Brief. 2025 Dec;(542):1–10. DOI: https://dx.doi.org/10.15620/cdc/174628
  3. 3. Centers for Disease Control and Prevention. 2022 Assisted Reproductive Technology (ART) Fertility Clinic and National Summary Report. US Dept of Health and Human Services, 2024.
Our Solution: Diagnosis FemVue.com →

Diagnose earlier & faster with
hers and his diagnostics.

Diagnosis is a critical first-step in guiding both female patients and their male partners toward treatment.

  • Performed in-office
  • No referral to radiology
  • Completed in less than 15 minutes
  • Ultrasound-based with immediate results
  • Uses natural saline-air contrast
  • Can be combined with SIS for a complete infertility assessment
  • Performed at-home
  • No lab visit or mail-in required
  • 97% accurate⁴
  • Results in less than 20 minutes
  • Comprehensive report of concentration and motility
  • Private and convenient for patients
  1. 4. Agarwal A, et al. Home sperm testing device versus laboratory sperm quality analyzer: comparison of motile sperm concentration. Fertility and Sterility, December 2018.
Our Solution: Treatment FemaSeed.com →

Treat earlier & better with
FemaSeed® Complete.

Designed to better align with natural fertilization and enable earlier treatment through an OB/GYN or specialist.

  • Performed in-office
  • 2x the pregnancy rate of IUI for low sperm count⁵
  • Sperm delivery directly to the fallopian tube(s)
  • Simple transcervical procedure
  • Streamlined workflow
  • First-line alternative to historic IUI
  • Minimal staff time
  • CLIA waived
  • In-office solution
  • Streamlined workflow
  • No additional staff
  1. 5. Liu JH, et al. (2024). FemaSeed Directional Intratubal Artificial Insemination for Couples with Male-Factor or Unexplained Infertility Associated with Low Male Sperm Count. J Gynecol Reprod Med, 8(2), 01–12. doi: 10.33140/JGRM.08.02.08.
Clinical Evidence

Over 2x more effective
than historic IUI.⁵

“Targeted intratubal insemination of washed spermatozoa using the FemaSeed ITI device is a safe artificial insemination technique that demonstrated high effectiveness for couples with male-factor/unexplained infertility associated with low male sperm count.”⁵

Download FemaSeed Publication
1 in 4 women achieved pregnancy⁵
Pregnancy Rate Per Cycle — FemaSeed® vs. IUI Control
17.5%
FemaSeed® ITI⁵
6.7%
Historical IUI Control⁶
  1. 6. Duran et al. (2002). Intrauterine insemination: a systematic review on determinants of success. Human Reproduction, vol.8, no.4, pp.373–384.